by James Rudge, PhD, Technical Director, Neoteryx | 5 min read
An article published by Mirjana Radovanovic et al from multiple institutions in Australia, in the January 2022 issue of the Journal of Chromatography B, reported on the development and validation …
Read Storyby Neoteryx | 2 min read
In 2008, James Rudge, PhD, got the idea to invent a medical device for specimen collection that would be an advance on the dried blood spot (DBS) filter cards already …
Read Storyby Guest Contributor | 5 min read
A unique course at Ghent University in Belgium educates undergraduate pharmacy students on how to apply microsampling in the field of bioanalysis. This blog from Ghent University faculty Members describes …
Read Storyby Neoteryx | 4 min read
If you are a researcher seeking to learn more about microsampling and how it works, you can find many resources to help you on the Neoteryx website. Are you wondering …
Read Storyby James Rudge, PhD, Technical Director, Neoteryx | 5 min read
An analytical validation comparing plasma/serum to dried blood. An article first published on July 1, 2020 in the Annals of Clinical Biochemistry by David J Marshall et al from the clinical biochemistry department at Wythenshawe Hospital (South Manchester, UK) …
Read Storyby Neoteryx | 2 min read
Using dried microsamples collected through fingerstick sampling for research studies can often replace the traditional practice of using venipuncture to collect liquid blood samples in vials. Dried specimen microsampling reduces …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.